Ilex Medical Statistics
Total Valuation
Ilex Medical has a market cap or net worth of ILS 703.35 million. The enterprise value is 521.07 million.
Market Cap | 703.35M |
Enterprise Value | 521.07M |
Important Dates
The last earnings date was Thursday, March 27, 2025.
Earnings Date | Mar 27, 2025 |
Ex-Dividend Date | Apr 7, 2025 |
Share Statistics
Ilex Medical has 11.28 million shares outstanding. The number of shares has decreased by -0.13% in one year.
Current Share Class | n/a |
Shares Outstanding | 11.28M |
Shares Change (YoY) | -0.13% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 62.25% |
Owned by Institutions (%) | 17.64% |
Float | 2.94M |
Valuation Ratios
The trailing PE ratio is 15.24.
PE Ratio | 15.24 |
Forward PE | n/a |
PS Ratio | 0.76 |
PB Ratio | 1.09 |
P/TBV Ratio | 1.13 |
P/FCF Ratio | 13.56 |
P/OCF Ratio | 8.62 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.80, with an EV/FCF ratio of 10.05.
EV / Earnings | 13.37 |
EV / Sales | 0.57 |
EV / EBITDA | 4.80 |
EV / EBIT | 8.75 |
EV / FCF | 10.05 |
Financial Position
The company has a current ratio of 2.68, with a Debt / Equity ratio of 0.08.
Current Ratio | 2.68 |
Quick Ratio | 1.87 |
Debt / Equity | 0.08 |
Debt / EBITDA | 0.44 |
Debt / FCF | 0.99 |
Interest Coverage | 8.58 |
Financial Efficiency
Return on equity (ROE) is 7.20% and return on invested capital (ROIC) is 6.09%.
Return on Equity (ROE) | 7.20% |
Return on Assets (ROA) | 4.15% |
Return on Invested Capital (ROIC) | 6.09% |
Return on Capital Employed (ROCE) | 9.19% |
Revenue Per Employee | 4.13M |
Profits Per Employee | 174,803 |
Employee Count | 223 |
Asset Turnover | 0.92 |
Inventory Turnover | 4.43 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.03% in the last 52 weeks. The beta is 0.08, so Ilex Medical's price volatility has been lower than the market average.
Beta (5Y) | 0.08 |
52-Week Price Change | -9.03% |
50-Day Moving Average | 6,662.28 |
200-Day Moving Average | 6,897.38 |
Relative Strength Index (RSI) | 46.58 |
Average Volume (20 Days) | 8,024 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ilex Medical had revenue of ILS 920.37 million and earned 38.98 million in profits. Earnings per share was 3.49.
Revenue | 920.37M |
Gross Profit | 216.31M |
Operating Income | 66.72M |
Pretax Income | 61.60M |
Net Income | 38.98M |
EBITDA | 115.81M |
EBIT | 66.72M |
Earnings Per Share (EPS) | 3.49 |
Balance Sheet
The company has 233.63 million in cash and 51.35 million in debt, giving a net cash position of 182.28 million or 16.16 per share.
Cash & Cash Equivalents | 233.63M |
Total Debt | 51.35M |
Net Cash | 182.28M |
Net Cash Per Share | 16.16 |
Equity (Book Value) | 646.49M |
Book Value Per Share | 57.88 |
Working Capital | 450.60M |
Cash Flow
In the last 12 months, operating cash flow was 81.63 million and capital expenditures -29.76 million, giving a free cash flow of 51.87 million.
Operating Cash Flow | 81.63M |
Capital Expenditures | -29.76M |
Free Cash Flow | 51.87M |
FCF Per Share | 4.60 |
Margins
Gross margin is 23.50%, with operating and profit margins of 7.25% and 4.24%.
Gross Margin | 23.50% |
Operating Margin | 7.25% |
Pretax Margin | 6.69% |
Profit Margin | 4.24% |
EBITDA Margin | 12.58% |
EBIT Margin | 7.25% |
FCF Margin | 5.64% |
Dividends & Yields
This stock pays an annual dividend of 1.36, which amounts to a dividend yield of 2.16%.
Dividend Per Share | 1.36 |
Dividend Yield | 2.16% |
Dividend Growth (YoY) | -10.63% |
Years of Dividend Growth | n/a |
Payout Ratio | 39.16% |
Buyback Yield | 0.13% |
Shareholder Yield | 2.29% |
Earnings Yield | 5.54% |
FCF Yield | 7.37% |
Stock Splits
The last stock split was on August 21, 2000. It was a forward split with a ratio of 9.
Last Split Date | Aug 21, 2000 |
Split Type | Forward |
Split Ratio | 9 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |